EUVIMEDEUVIMED entdecken
Crossref

Non-immobilized graphene oxide–based screening of aptamers for non-small cell lung cancer (NSCLC) drug resistance biomarkers and development of a nano-detection platform

Qiming Kou, Lianju Chen, Jie Qu, Xu Wen, Qijun Zuo, Huimin Zhao, Yuanning Luo, Haoxiang Yan, Fan Zhang, Yanyan Wang, Yulong Li, Tianyu Feng und 3 weitere

Microchimica Acta · 2026

DOI: 10.1007/s00604-025-07809-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microchimica Acta, 2026. Verfasst von Qiming Kou und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Abdominal Tumor Multimodality Treatment, Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, No.37 …. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Graphite. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: doctoral Research of Jilin Medical University, The department of Science and Technology of Sichuan Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aptamers, NucleotideCarcinoma, Non-Small-Cell LungLung NeoplasmsGraphiteDrug Resistance, NeoplasmBiomarkers, TumorHumansSELEX Aptamer TechniqueMetal NanoparticlesGoldIndolesLimit of DetectionCell Line, TumorPyrimidinesAniline CompoundsAcrylamidesBiosensing Techniques

Stichwörter der Autor:innen

AptamerAptamer sensing platformImmunoblotting analysisNon-small cell lung cancer (NSCLC)SDS-PAGE electrophoresis

Substanzen

Aptamers, NucleotideGraphitegraphene oxideGoldBiomarkers, TumorIndolesPyrimidinesAniline CompoundsosimertinibAcrylamides

Autor:innen und Institutionen

  • Division of Abdominal Tumor Multimodality Treatment, Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, No.37 Guoxue Alley, Chengdu, Sichuan, 610041, China. kouqiminga@163.com.
  • School of Laboratory Medicine, Jilin Medical University, Jilin, Jilin 132013, China. kouqiminga@163.com.
  • State Key Laboratory of Biotherapy, Sichuan University, Chengdu, Sichuan, 610041, China. kouqiminga@163.com.
  • School of Laboratory Medicine, Jilin Medical University, Jilin, Jilin 132013, China.
  • State Key Laboratory of Biotherapy, Sichuan University, Chengdu, Sichuan, 610041, China.
  • College of Food Engineering, Chongqing Vocational College of Light Industry, Chongqing, 401329, China.

Förderung

  • doctoral Research of Jilin Medical University
  • The department of Science and Technology of Sichuan Province
  • National Natural Science Foundation of China

Zitieren

APA

Kou, Q., Chen, L., Qu, J., Wen, X., Zuo, Q., Zhao, H., Luo, Y., Yan, H., Zhang, F., Wang, Y., Li, Y., Feng, T., Wang, H., Sun, K., & Zhao, G. (2026). Non-immobilized graphene oxide–based screening of aptamers for non-small cell lung cancer (NSCLC) drug resistance biomarkers and development of a nano-detection platform. Microchimica Acta. https://doi.org/10.1007/s00604-025-07809-3

Vancouver

Kou Q, Chen L, Qu J, Wen X, Zuo Q, Zhao H, et al. Non-immobilized graphene oxide–based screening of aptamers for non-small cell lung cancer (NSCLC) drug resistance biomarkers and development of a nano-detection platform. Microchimica Acta. 2026. doi:10.1007/s00604-025-07809-3

BibTeX
@article{Kou2026,
  author = {Kou, Qiming and Chen, Lianju and Qu, Jie and Wen, Xu and Zuo, Qijun and Zhao, Huimin and Luo, Yuanning and Yan, Haoxiang and Zhang, Fan and Wang, Yanyan and Li, Yulong and Feng, Tianyu and Wang, Huiyan and Sun, Kexin and Zhao, Gang},
  title = {Non-immobilized graphene oxide–based screening of aptamers for non-small cell lung cancer (NSCLC) drug resistance biomarkers and development of a nano-detection platform},
  journal = {Microchimica Acta},
  year = {2026},
  doi = {10.1007/s00604-025-07809-3}
}
Kostenlos starten →